Twenty One Capital’s NYSE listing showed how tightly markets now price Bitcoin-heavy firms, with investors refusing to pay much beyond the underlying BTC value.
You might also be interested in reading Stalicla secures CHF 2M investment led by Addex for neuropsychiatric drug development.